- 작성자 : ILIAS Biologics
- 작성일 : 20-11-04 11:39
- 조회 : 271회
28 Oct 2020
ILIAS Biologics begins KOSDAQ listing process
ILIAS Biologics has been recently finalizing the underwriter contract with two securities companies, Kiwoom Securities and Daishin Securities, preparing for an initial public offering (IPO) on the KOSDAQ (Korea Securities Dealers and Automated Quotation) in Q1 2022.
We are grateful for the trust they have shown us from investing in Series B to participating as an underwriter.
Please find the link below for more information.